125016-87-7

Basic information

• Product Name: Benzene, 1,1'-(methoxyphenylmethylene)bis[4-methoxy-
• CAS NO: 125016-87-7
• Molecular Formula: C22H22O3
• Molecular Weight: 334.415
• Mol File: 125016-87-7.mol
• Article Data: 19

Chemical Properties

• CAS DataBase Reference: Benzene, 1,1'-(methoxyphenylmethylene)bis[4-methoxy-(CAS DataBase Reference)
• NIST Chemistry Reference: Benzene, 1,1'-(methoxyphenylmethylene)bis[4-methoxy-(125016-87-7)
• EPA Substance Registry System: Benzene, 1,1'-(methoxyphenylmethylene)bis[4-methoxy-(125016-87-7)

Safety Data

• Hazardous Substances Data: 125016-87-7(Hazardous Substances Data)

Upstream product

• 67-56-1 methanol 
• 40615-36-9 4,4'-dimethoxytrityl chloride 
• 124-41-4 sodium methylate 
• 611-94-9 4-Methoxybenzophenone 
• 104-92-7 1-bromo-4-methoxy-benzene 
• 40615-35-8 4,4'-dimethoxytrityl alcohol 
• 163759-49-7 2'-O-(2-methoxyethyl)-5-methyluridine 

Downstream Products

• 1542574-89-9 O^5'-(4,4’-dimethoxytrityl)-N²-(dimethylformamidine)-2-aminothieno[3,4-d]pyrimidine 
• 40615-35-8 4,4'-dimethoxytrityl alcohol 

Relevant articles and documents

The Mechanism of Deamination of Methoxy Substituted Tritylammonium Ions in Methanolic Aqueous Acid

In methanolic aqueous acid, methoxy-substituted tritylammonium ions undergo heterolysis to give an equilibrium mixture of the substituted trityl cation, the corresponding alcohol (and methyl ether), and the ammonium cation via an SN1 mechanism; the detection of a reaction channel first order in hydronium ions may implicate substituted trityl cation-ammonia (ion-molecule) pairs as reactive intermediates.

Antisense modulation of resistin expression

Antisense compounds, compositions and methods are provided for modulating the expression of resistin. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding resistin. Methods of using these compounds for modulation of resistin expression and for treatment of diseases associated with expression of resistin are provided.

Antisense modulation of PTPRA expression

Antisense compounds, compositions and methods are provided for modulating the expression of PTPRA. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding PTPRA. Methods of using these compounds for modulation of PTPRA expression and for treatment of diseases associated with expression of PTPRA are provided.